Navigation Links
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Date:5/4/2009

r.

About Linaclotide

Linaclotide is a first-in-class compound in Phase 3 clinical development for the treatment of IBS-C and chronic constipation (CC). Linaclotide demonstrated proof of concept in a comprehensive Phase 2b program, comprised of two clinical studies in over 700 patients with either IBS-C or CC. In patients with IBS-C, linaclotide significantly reduced abdominal pain and bloating and improved bowel function throughout the 12-week treatment period. In patients with CC, linaclotide reduced constipation throughout the 4-week treatment period. In both studies the most common adverse event was diarrhea. Linaclotide is a once daily, orally delivered peptide that acts locally in the gut with no detectable systemic exposure at therapeutic doses. Linaclotide is an agonist of guanylate cyclase type-C, a receptor found on the lining of the intestine. Issued composition of matter patents for linaclotide in the United States and Europe provide protection beyond 2024. In September 2007, Ironwood and Forest Laboratories, Inc. entered into a 50/50 collaboration to co-develop and co-promote linaclotide in United States.

About Irritable Bowel Syndrome with Constipation (IBS-C)

IBS-C is a chronic functional gastrointestinal disorder characterized by abdominal pain and discomfort associated with altered bowel habits. There are currently few available therapies to treat this disorder. In the five major European markets alone, an estimated nine million patients suffer from IBS-C. Patients suffering from IBS-C can be affected physically, psychologically, socially, and economically.

About Almirall

Almirall is an international pharmaceutical company based on innovation and committed to health. Headquartered in Barcelona, Spain, Almirall researches, develops, manufactures, and commercializes its own R&D and licensed drugs with the aim of improving people's health and wellbeing
'/>"/>

SOURCE Ironwood Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
5. Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... MIRAMAR BEACH, Fla. , June 30, 2015  July ... our country,s declaration of independence, and the spirit and people ... For Heroes Foundation has partnered with USA ... cards, to help increase funding for programs that empower independence ... across the country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/pggcjf/global_endoscopy ) has announced ... Market 2015-2019" report to their offering. ... at a CAGR of 5.53% over the period ... be segmented into three based on products: endoscopes, ... be further segments in terms of application: arthroscopy, ...
(Date:6/30/2015)... , BERKELEY, Calif. and ... CMC Biologics, Inc. , a global ... and other therapeutic proteins, announced today that, as part ... completed the expansion of its North American manufacturing facility ... addition of a single-use Bioreactor 6Pack™ facility.  The Bioreactor ...
Breaking Medicine Technology:Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3
... UCB, Inc. today announced an agreement with the U.S. ... investigation into the marketing and promotion of Keppra®, an anti-epileptic ... subject of this investigation occurred more than six years ago, ... with the United States since learning of the investigation in ...
... hoc analysis from the RECOVER study (Randomized Evaluation of ... that patients with Parkinson,s disease who used Neupro® (rotigotine ... mood/cognition, such as taking interest in surroundings and getting ... presented from a one year open label follow-up of ...
Cached Medicine Technology:UCB, Inc. Resolves Investigation of Past Keppra® Marketing and Promotional Activities 2Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 2Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 3Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 4Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 5Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinson's Disease 6
(Date:6/30/2015)... Los Angeles, California (PRWEB) , ... June 30, ... ... store that specializes in Middle eastern, Persian and Mediterranean foods and groceries. ... orders., Just in time for the BBQ season, http://persianbazzar.com added great ...
(Date:6/30/2015)... , ... June 30, 2015 , ... White Blitz ... expanding its suite of products to mobile teeth whitening entrepreneurs. Mobile teeth whitening is ... that offer convenience and a personal touch. The popularity of the industry has spawn ...
(Date:6/30/2015)... ... June 30, 2015 , ... Ticket Down announces that they have slashed prices across ... legendary Pantages Theatre. For the past 26 years, “The Phantom of the Opera” ... this musical, originally written by Gaston Leroux, and converted into a musical by Andrew Lloyd ...
(Date:6/30/2015)... ... , ... According to research by European archeologists that was recently discussed in ... hundred thousand years ago likely knew that eating a balanced diet and limiting smoke ... dental plaque, researchers were able to find evidence of plant fibers, in addition to ...
(Date:6/30/2015)... Santa Monica, CA (PRWEB) , ... June 30, ... ... release of its new YouTube video, “Fireside Convalescent Care Center.” The video informs ... create the video after continually seeing the need for those seeking care to ...
Breaking Medicine News(10 mins):Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 2Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 3Health News:White Blitz to Develop New Mobile Teeth Whitening Program for Entrepreneurs 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 3Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2
... Cyclist Davis Phinney, Diagnosed with Parkinson,s Disease at ... The DiseaseMINNEAPOLIS, April 09 Medtronic, Inc. (NYSE: ... forces with the Davis Phinney Foundation to raise ... caregivers about how to improve their lives today. ...
... Ensign Group, Inc. (Nasdaq: ENSG ) announced ... in Ogden, Utah has successfully graduated from the Centers ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO )"It was a team effort, and ... we strive to make Mt. Ogden the Ogden area,s ...
... as little as $57 a monthSPRINGFIELD, Ill., April 9 ... College Illinois !(SM) , the state,s ... Incentive Program. With only a few weeks left to ... the decision to enroll easier by giving qualifying purchasers ...
... one of the Largest Union Votes at a Boston ... decades, workers unite for the best patient care, for their families ... St. Elizabeth,s Medical Center, the largest medical center in the Caritas ... election conducted by the National Labor Relations Board, by 73% to ...
... performance cell culture media components will reveal significant advantages of its ... 20-22 in San Francisco. , ... Fort Collins, CO ... culture media components used for mammalian cell culture will be showcased ...
... DIEGO, April 9 CardioDynamics (Nasdaq: CDIC ), the innovator ... fiscal first quarter 2009. Financial Highlights of First ... , , ... a 3% increase excluding large Eastern European hospital group sales in the ...
Cached Medicine News:Health News:Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinson's Disease 2Health News:Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinson's Disease 3Health News:The Ensign Group Successfully Graduates Third Nursing Home From CMS Special Focus Program 2Health News:57 (More) Reasons to Buy a Contract From College Illinois!(SM) 2Health News:57 (More) Reasons to Buy a Contract From College Illinois!(SM) 3Health News:More than 800 Workers at Caritas St. Elizabeth's Medical Center Make History with Vote to join 1199SEIU 2Health News:More than 800 Workers at Caritas St. Elizabeth's Medical Center Make History with Vote to join 1199SEIU 3Health News:InVitria Headlines Sponsorship of WilBio's Waterside Conference 2Health News:CardioDynamics Reports First Quarter 2009 Results 2Health News:CardioDynamics Reports First Quarter 2009 Results 3Health News:CardioDynamics Reports First Quarter 2009 Results 4Health News:CardioDynamics Reports First Quarter 2009 Results 5Health News:CardioDynamics Reports First Quarter 2009 Results 6
All welded construction for strength and durability. Choice of stainless steel or chrome plated models. One forward leg with caster for increased mobility....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Ideal for surgical procedures, these portable stands fit into tight areas for easy instrument access. Easy placement over patient....
Fixed chair back and armrests, electric lift with 8" (20.3cm) stroke, foot pedal control, choice of upholstery colors. Optional features: 15 tilt mechanism and footrest, locking rotation, sliding arm...
Medicine Products: